EUVIMEDEUVIMED entdecken
Open Access

RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination

Carolina Galan iD, Guangqing Lu iD, Richard Gill, Dun Li, Yifang Liu iD, Jun R Huh, Saiyu Hang

The Journal of Immunology · 2025

DOI: 10.1093/jimmun/vkae043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Carolina Galan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Genentech, Inc, South San Francisco, CA, United States. Hauptthemen laut MEDLINE: Th17 Cells, Cell Differentiation, Epigenesis, Genetic, Histones. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A gene encoding the transcription factor RTF1 has been associated with an increased risk of ulcerative colitis (UC). In this study, we investigated its function in modulating T cells expressing interleukin-17A (Th17 cells), a cardinal cell type promoting intestinal inflammation. Our results indicate that Rtf1 deficiency disrupts the differentiation of Th17 cells, while leaving regulatory T cells (Treg) unaffected. Mechanistically, RTF1 facilitates histone H2B monoubiquitination (H2Bub1), which requires its histone modification domain (HMD), for supporting Th17 cell function. Impaired Th17 differentiation was also observed in cells lacking the H2Bub1 E3 ligase subunit RNF40, an enzyme known to physically interact with RTF1. Thus, our study underscores the essential role of RTF1 in H2Bub1-mediated epigenetic regulation of Th17 cell differentiation. Understanding this process will likely provide valuable insights into addressing Th17-associated inflammatory disorders. (Images were created with BioRender).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Th17 CellsCell DifferentiationEpigenesis, GeneticHistonesTranscription FactorsUbiquitinationAnimalsMiceUbiquitin-Protein LigasesMice, Inbred C57BLMice, KnockoutColitis, UlcerativeInterleukin-17HumansT-Lymphocytes, Regulatory

Stichwörter der Autor:innen

H2B monoubiquitinationRNF40RTF1Th17 differentiation

Substanzen

HistonesUbiquitin-Protein LigasesInterleukin-17Transcription Factors

Autor:innen und Institutionen

  • Genentech, Inc, South San Francisco, CA, United States.
  • Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.
  • Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.
  • Bio2Q, Keio University, Tokyo, Japan.

ORCID-Profile: Carolina Galan, Guangqing Lu, Yifang Liu

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Galan, C., Lu, G., Gill, R., Li, D., Liu, Y., Huh, J. R., & Hang, S. (2025). RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkae043

Vancouver

Galan C, Lu G, Gill R, Li D, Liu Y, Huh JR, et al. RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkae043

BibTeX
@article{Galan2025,
  author = {Galan, Carolina and Lu, Guangqing and Gill, Richard and Li, Dun and Liu, Yifang and Huh, Jun R and Hang, Saiyu},
  title = {RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination},
  journal = {The Journal of Immunology},
  year = {2025},
  doi = {10.1093/jimmun/vkae043}
}
Kostenlos starten →